Found 36 matching trials
Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection PHASE3 Hepatitis C virus (HCV) infection is a leading cause of death and illness i...
Show More Learn More & Join Trial
Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy PHASE4 The purpose of this study is to evaluate the impact of a physician directed...
Show More Location
California Liver Institute
Learn More & Join Trial
A Collaborative Trial in Injectors of Individualized Treatment for Genotype 2/3 PHASE4 This sudy will determine whether shortening treatment for hepatitis C is fe...
Show More Location
Hunter Pharmacotherapy
Learn More & Join Trial
Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B PHASE2 Hepatitis B virus (HBV) causes a wide spectrum of liver diseases, such as f...
Show More Location
Multiple Locations
Learn More & Join Trial
Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED) PHASE4 This is an Australian, open-label, multicenter, randomized, double-blind cl...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of the Combination Vitamin D With Standard of Care in Egyptian Patients With Untreated Chronic Hepatitis C PHASE3 The purpose of this study is to show the superiority of a 4 weeks lead-in p...
Show More Learn More & Join Trial
Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection PHASE2 Objectives: 1. Primary objective: To Evaluate the rate of sustained virolog...
Show More Learn More & Join Trial
Study of Safety, Tolerability, and Anti-Viral Effect of Locteron Compared to PEG-Intron in Patients With Chronic Hepatitis C PHASE1 The purposes of the PLUS study were to confirm the safety and tolerability ...
Show More Location
Henry Ford Hospital
Learn More & Join Trial
Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV PHASE2 The purpose of the study was to assess in subjects with chronic hepatitis C...
Show More Learn More & Join Trial
Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin PHASE2 The majority of Human immunodeficiency Virus (HIV)/Hepatitis C Virus (HCV) ...
Show More Location
CHU Sainte Marguerite
Learn More & Join Trial